Corvex, Inc.

For the period ended Jun 30, 2026. Filed Aug 14, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 14, 2026

MOVE$4.96-1.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) (UNAUDITED)

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

Additional · Total
Preferred Stock · Common Stock · Paid-In · Accumulated · Stockholders’
Three Months Ended June 30, 2025	Shares	Amount	Shares	Amount	Capital	Deficit	Equity
Balance at March 31, 2025	–	$–	955,552	$10	$156,509	$(153,285)	$3,234
Stock-based compensation	–	–	–	–	780	–	780
Issuance of common stock	–	–	171,750	–	848	–	848
Net loss	–	–	–	–	–	(3,225)	(3,225)
Balance at June 30, 2025	–	$–	1,127,302	$10	$158,137	$(156,510)	$1,637

Additional · Total
Preferred Stock · Common Stock · Paid-In · Accumulated · Stockholders’
Six Months Ended June 30, 2025	Shares	Amount	Shares	Amount	Capital	Deficit	Equity
Balance at December 31, 2024	–	$–	928,911	$10	$155,452	$(148,107)	$7,355
Stock-based compensation	–	–	–	–	1,079	–	1,079
Issuance of common stock	–	–	198,391	–	1,606	–	1,606
Net loss	–	–	–	–	–	(8,403)	(8,403)
Balance at June 30, 2025	–	$–	1,127,302	$10	$158,137	$(156,510)	$1,637

Additional · Total
Preferred Stock · Common Stock · Paid-In · Accumulated · Stockholders’
Three Months Ended June 30, 2026	Shares	Amount	Shares	Amount	Capital	Deficit	Equity
Balance at March 31, 2026	56,779	$577,319	1,921,809	$–	$170,125	$(171,397)	$576,047
Stock-based compensation	–	–	–	–	9,691	–	9,691
Conversion of Series A preferred stock into common stock	(196)	(186)	50,007	–	186	–	–
Transaction expense adjustments	–	–	–	–	207	–	207
Issuance of common stock upon exercise of stock options	–	–	77,406	–	71	–	71
Issuance of common stock from restricted stock units	–	–	11,416	–	–	–	–
Shares cancelled	–	–	(453)	–	–	–	–
Net loss	–	–	–	–	–	(12,765)	(12,765)
Balance at June 30, 2026	56,583	$577,133	2,060,185	$–	$180,280	$(184,162)	$573,251

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

Total
Preferred Stock · Common Stock · Paid-In · Accumulated · Stockholders’
Six Months Ended June 30, 2026	Shares	Amount	Shares	Amount	Capital	Deficit	Equity/(Deficit)
Balance at December 31, 2025	3,000	$2,850	1,228,272	$10	$160,058	$(166,392)	$(3,474)
Stock-based compensation	–	–	–	–	11,869	–	11,869
Conversion of Series A preferred stock into common stock	(196)	(186)	50,007	–	186	–	–
Transaction expense adjustments	–	–	–	–	207	–	207
Series B preferred stock issued in connection with the Merger	241	2,576	–	–	–	–	2,576
Series C preferred stock issued in connection with the Merger	23,552	250,737	–	–	–	–	250,737
Series D preferred stock issued in connection with the Merger	30,227	323,732	–	–	–	–	323,732
Common stock issued upon conversion of Series B Preferred stock	(241)	(2,576)	240,544	–	2,576	–	–
Issuance of common stock upon exercise of stock options	–	–	504,650	–	464	–	464
Par value adjustment for stock splits and stock dividend	–	–	–	(10)	10	–	–
Issuance of replacement awards in connection with Merger	–	–	–	–	4,910	–	4,910
Issuance of common stock from restricted stock units	–	–	37,165	–	–	–	–
Shares cancelled	–	–	(453)	–	–	–	–
Net loss	–	–	–	–	–	(17,770)	(17,770)
Balance at June 30, 2026	56,583	$577,133	2,060,185	$—	$180,280	$(184,162)	$573,251

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.